Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

甲状腺疾患におけるT3/T4比

P G Walfish

    Lancet (London, England)
    |November 11, 1978
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer.

    Oncogenesis·2015
    Same author

    Clinical application of triiodothyronine measurement.

    Canadian Medical Association journal·2010
    Same author

    Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.

    Journal of endocrinological investigation·2004
    Same author

    Requirement of co-factors for the ligand-mediated activity of the insect ecdysteroid receptor in yeast.

    Journal of molecular endocrinology·2001
    Same author

    Cause of death in patients with well-differentiated thyroid carcinoma.

    The Laryngoscope·2001
    Same author

    GCN5 and ADA adaptor proteins regulate triiodothyronine/GRIP1 and SRC-1 coactivator-dependent gene activation by the human thyroid hormone receptor.

    Molecular endocrinology (Baltimore, Md.)·2000
    Same journal

    Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

    Lancet (London, England)·2026
    Same journal

    Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

    Lancet (London, England)·2026
    Same journal

    Inherited retinal degenerations: clinical phenotypes and emerging therapies.

    Lancet (London, England)·2026
    Same journal

    Documenting hospice care.

    Lancet (London, England)·2026
    Same journal

    After the wood chipper.

    Lancet (London, England)·2026
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    関連記事をすべて見る